Inve India ▾

Max India share price & results

Max India Ltd· Financial Services

Results to
Jun 2026
Latest analysed call
Q1 FY27
Ownership as of
Sept 2026

Indian senior-care holding company operating residential communities for seniors (Antara), assisted-care services (Care Homes, Care at Home) and a D2C senior-wellness products platform (AGEasy).

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue60.0 ₹ crore+62.2% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin-58.0 %+18.0 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit-36.0 ₹ crore—Quarterly, as filedQuarter to Jun 2026Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown.
Return on equity-33.59 %−3.0 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin-68.72 %+25.1 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)36.31 %+44.1 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Guidance

What management said, and what became of it

2 of 4 judged targets kept · 10 open · verdicts reflect calls analysed to Q1 FY27.

Max India Ltd management guidance track record on Inve: 14 targets tracked across analysed earnings calls (2 achieved, 2 missed, 10 open).

TargetOriginal wordingSaidLatest callVerdict
Estate 361 Project LaunchLaunched by September, October this year
Call transcript, Q1 FY26 · 6 Aug 2025		Q1 FY26Q1 FY27:Project launch is complete. Company reported 154 bookings by June end, with 27 units sold in Q1.
Call transcript, Q1 FY27 · 12 Aug 2026		Achieved*
Annual Real Estate Development1.5 million square feet every year
Call transcript, Q3 FY25 · 7 Feb 2025		Q3 FY25Q1 FY27:Focus has shifted to the new FY27 target of 2 million sq ft. No update on the original 'every year' commitment.
Call transcript, Q1 FY27 · 12 Aug 2026		Missed
Consolidated EBITDA BreakevenBreakeven on a consolidated basis by FY27-FY28
Call transcript, Q3 FY25 · 7 Feb 2025		Q3 FY25Q1 FY27:Consolidated EBITDA loss worsened to INR 25 crores in Q1 FY27. Management states the trajectory of loss reduction will continue, but the quarterly performance puts the target at risk.
Call transcript, Q1 FY27 · 12 Aug 2026		At Risk

Source: Inve Guidance Tracker for Max India Ltd · to Q1 FY27

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

2 of Max India Ltd's 14 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 11 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹149.29 +0.09% · +₹0.14

Last close 26 Oct 2026 · NSE · INR · Source: Inve

Performance −30.0% 1Y

₹120₹140₹160₹180₹200₹220Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q2 FY26 — 14 Nov 2025Q3 FY26 — 10 Feb 2026Q4 FY26 — 29 May 2026Q1 FY27 — 12 Aug 2026

1Y: ₹213.19 on 24 Oct 2025 → ₹149.29. High ₹216.89 (27 Oct 2025), low ₹122.85 (30 Mar 2026).

Previous close
₹149.15
Market cap
₹846 Cr
52-week range
₹122.85 – ₹216.89
One year
−31.17%
Return on equity (TTM to Jun 2026)
-33.59%

Overview

Symbol
NSE:MAXIND
Exchange
NSE
Currency
INR

What Max India Ltd does

Based on the company's own presentations, annual report and earnings calls.

Max India Limited is the holding company for Max Group's senior-care business, operating through two wholly owned subsidiaries: Antara Senior Living Limited (Residences for Seniors) and Antara Assisted Care Services Limited (Care Homes, Care at Home and Antara AGEasy). It develops and manages senior living residential communities (e.g. Dehradun, Noida, and towers within Max Estates' Gurugram projects), runs assisted-care facilities offering long-term and short-term nursing/medical supervision plus at-home care for seniors, and sells senior-wellness products (joint & pain, fall, lung and gut-health categories) via AGEasy's marketplace and direct-to-consumer channels.

Segments

  • Residences for Seniors (Antara Senior Living)
  • Assisted Care Services
  • AGEasy
Care Homes bed capacity
485 beds across NCR (207), Bengaluru (163) and Chennai (115)
Senior living residential communities
4 (Dehradun, Noida Phase 1, E360 Gurugram, E361 Gurugram)
AGEasy product portfolio
110 total products, 91 live products, 159 SKUs
Lives served via AGEasy since inception
~7 lacs+ (Marketplace ~5.3 lacs; D2C ~2.5 lacs)
AGEasy repeat customers
78,000+
Patients served at Care Homes since inception
50,500+
Founded 2020Headquarters Gurgaon, Haryana Company website

How the price took the results

close before → close after

Q1 FY27
−4.6%
12 Aug
Q4 FY26
−7.3%
29 May
Q3 FY26
+0.0%
10 Feb
Q2 FY26
−1.6%
14 Nov

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for Max India Ltd

Free account: one company. Everything above stays public.

Write why you follow Max India Ltd and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Financial Services companies

All Financial Services companies → · Financial Services earnings growth →

Learn to analyse Max India Ltd

Guides on how to read this kind of business and the numbers that matter.